Orbimed Advisors LLC Synlogic, Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$2.45 - $4.1 $5.72 Million - $9.57 Million	2,333,333 Added 63.12%	6,029,995 $18.4 Million
Q2 2021 Aug 16, 2021	BUY	$3.0 - $4.39 $5 Million - $7.32 Million	1,666,666 Added 82.1%	3,696,662 $14.4 Million
Q1 2018 May 15, 2018	BUY	$9.38 - $12.12 $6.71 Million - $8.67 Million	715,000 Added 54.37%	2,029,996 $19 Million
Q3 2017 Nov 14, 2017	BUY	$11.55 - $21.79 $15.2 Million - $28.7 Million	1,314,996	1,314,996 $25 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.